Ricardo Machado Soares
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ricardo Machado Soares has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Catarina Ferreira
Department of Ophthalmology, Unidade Local de Saúde Gaia/Espinho, Vila Nova de Gaia, Portugal
3 shared publications Lígia Ribeiro
Department of Ophthalmology - Centro Hospitalar Vila Nova de Gaia e Espinho, Porto, Portugal
3 shared publicationsCarlos Arêde
Department of Ophthalmology, Centro Hospitalar de Vila Nova de Gaia e Espinho EPE, Portugal
2 shared publicationsCatarina Cunha Ferreira
Department of Ophthalmology - Centro Hospitalar de Vila Nova de Gaia e Espinho EPE, Porto, Portugal
2 shared publications- Joana Braga
Ophthalmology Department Centro Hospitalar Vila Nova de Gaia e Espinho Vila Nova de Gaia Portugal
2 shared publications Joana Da Silva Fernandes
Ophthalmology Department Centro Hospitalar Vila Nova de Gaia e Espinho Vila Nova de Gaia Portugal
2 shared publications
Latest Publications
- 19 October 2026
- Published by Wolters Kluwer Health in Cornea
Contact Lens–Assisted Femtosecond Laser Harvesting of Donor Bowman Layer Grafts: A Pilot In Vitro Study With Preliminary Clinical Application in Advanced Keratoconus
Purpose: To describe and evaluate a pilot technique using a sterile bandage contact lens (CL) as a spacer to overcome the minimum-depth limitations of applanation-based femtosecond laser (FSL) platforms when harvesting thin donor Bowman layer (BL) grafts, with preliminary clinical application in BL transplantation for advanced keratoconus (KC). Methods: This experimental and interventional case series included 9 in vitro donor corneas and 4 in vivo eyes with progressive KC. A ∼70-μm plano CL was applied to the bare donor stroma. The FSL dissection depth was programmed by adding the intended graft thickness to the CL thickness (110 μm for a ∼40-μm BL graft). Graft thickness and morphology were evaluated via optical coherence tomography (OCT). For the clinical cases, grafts were implanted into FSL-created stromal pockets; in vivo outcomes were limited to anterior segment OCT assessment of graft integration, graft thickness, and central corneal thickness over 12 months of follow-up. Results: The combined success rate for graft preparation was 92.3% (12/13). In vitro BL grafts yielded a median central thickness of 70 μm. The in vivo BL grafts achieved a median central thickness of 46 μm, with a median deviation of 1.5 μm from the individualized targets. Over the 12-month follow-up, anterior segment OCT showed all grafts to remain well integrated within the stromal pocket, with no displacement or interface complications. Conclusions: In this pilot study, the CL-assisted FSL protocol proved a reproducible method for harvesting BL grafts. By bypassing the minimum depth constraints of widely used applanation-based FSL platforms, this technique may minimize tissue loss and expand surgical access to BL transplantation for managing advanced KC, pending confirmation in larger series.
- 19 October 2026
- Published by Wolters Kluwer Health in Cornea
Contact Lens–Assisted Femtosecond Laser Harvesting of Donor Bowman Layer Grafts: A Pilot In Vitro Study With Preliminary Clinical Application in Advanced Keratoconus
Purpose: To describe and evaluate a pilot technique using a sterile bandage contact lens (CL) as a spacer to overcome the minimum-depth limitations of applanation-based femtosecond laser (FSL) platforms when harvesting thin donor Bowman layer (BL) grafts, with preliminary clinical application in BL transplantation for advanced keratoconus (KC). Methods: This experimental and interventional case series included 9 in vitro donor corneas and 4 in vivo eyes with progressive KC. A ∼70-μm plano CL was applied to the bare donor stroma. The FSL dissection depth was programmed by adding the intended graft thickness to the CL thickness (110 μm for a ∼40-μm BL graft). Graft thickness and morphology were evaluated via optical coherence tomography (OCT). For the clinical cases, grafts were implanted into FSL-created stromal pockets; in vivo outcomes were limited to anterior segment OCT assessment of graft integration, graft thickness, and central corneal thickness over 12 months of follow-up. Results: The combined success rate for graft preparation was 92.3% (12/13). In vitro BL grafts yielded a median central thickness of 70 μm. The in vivo BL grafts achieved a median central thickness of 46 μm, with a median deviation of 1.5 μm from the individualized targets. Over the 12-month follow-up, anterior segment OCT showed all grafts to remain well integrated within the stromal pocket, with no displacement or interface complications. Conclusions: In this pilot study, the CL-assisted FSL protocol proved a reproducible method for harvesting BL grafts. By bypassing the minimum depth constraints of widely used applanation-based FSL platforms, this technique may minimize tissue loss and expand surgical access to BL transplantation for managing advanced KC, pending confirmation in larger series.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery Online Case Reports
- Vol. 13, e00172
Anterior capsulotomy for early postoperative capsular block syndrome: sequential imaging approach with AS-OCT
Introduction: Early postoperative capsular block syndrome (CBS) is a rare complication of cataract surgery. We aim to describe its clinical and serial imaging characteristics, through high-definition anterior segment optical coherence tomography (AS-OCT). Patient and Clinical Findings: A 65-year-old woman underwent cataract surgery. Poor pupillary dilation (5 mm) was noted, and the surgeon opted for a high-density cohesive–dispersive ophthalmic viscosurgical device (OVD) to induce viscomydriasis. The capsulorhexis was performed near the pupillary margin, and an intraocular lens (IOL) targeted to emmetropia was implanted. On postoperative day 1, the patient complained of reduced distance visual acuity. Refraction was −2.50 −1.00 × 70; anterior chamber depth (ACD) was reduced, and the edge of the capsulorhexis overlayed the edge of the IOL, which was separated from the posterior capsule by a transparent liquid. Diagnosis, Intervention, and Outcomes: Anterior capsulotomy was performed, which resulted in an ACD increase and less separation between the IOL and the posterior capsule; 1 hour later refraction was −0.50 −1.50 × 70. Serial AS-OCT confirmed the clinical diagnosis and depicted changes in anatomical relationships between referred structures. Conclusions: Early postoperative CBS is a rare complication of cataract surgery. Anterior capsulotomy is a safe option when preservation of the posterior capsule is advisable. Serial imaging with AS-OCT confirms the diagnosis and treatment success.
- 1 January 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery Online Case Reports
- Vol. 13, e00172
Open AccessAnterior capsulotomy for early postoperative capsular block syndrome: sequential imaging approach with AS-OCT
Introduction: Early postoperative capsular block syndrome (CBS) is a rare complication of cataract surgery. We aim to describe its clinical and serial imaging characteristics, through high-definition anterior segment optical coherence tomography (AS-OCT). Patient and Clinical Findings: A 65-year-old woman underwent cataract surgery. Poor pupillary dilation (5 mm) was noted, and the surgeon opted for a high-density cohesive–dispersive ophthalmic viscosurgical device (OVD) to induce viscomydriasis. The capsulorhexis was performed near the pupillary margin, and an intraocular lens (IOL) targeted to emmetropia was implanted. On postoperative day 1, the patient complained of reduced distance visual acuity. Refraction was −2.50 −1.00 × 70; anterior chamber depth (ACD) was reduced, and the edge of the capsulorhexis overlayed the edge of the IOL, which was separated from the posterior capsule by a transparent liquid. Diagnosis, Intervention, and Outcomes: Anterior capsulotomy was performed, which resulted in an ACD increase and less separation between the IOL and the posterior capsule; 1 hour later refraction was −0.50 −1.50 × 70. Serial AS-OCT confirmed the clinical diagnosis and depicted changes in anatomical relationships between referred structures. Conclusions: Early postoperative CBS is a rare complication of cataract surgery. Anterior capsulotomy is a safe option when preservation of the posterior capsule is advisable. Serial imaging with AS-OCT confirms the diagnosis and treatment success.
- Open Access
- 16 September 2024
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 19 (3) , 324-333
Predictive Factors for Functional and Anatomical Outcomes After Anti-VEGF Treatment for Macular Edema in Patients with Branch Retinal Vein Occlusion
Purpose: This study aimed to identify predictive factors for the improvement of best-corrected visual acuity (BCVA) and reduction of central macular thickness (CMT) after treatment of macular edema (ME) due to branch retinal vein occlusion (BRVO) in a real-world setting. Methods: This retrospective study included patients with ME secondary to BRVO who were treated with intravitreal injection of bevacizumab as the first-line therapy and were followed up for 12 months. Demographic and clinical data, in addition to baseline spectral domain optical coherence tomography (SD-OCT) features, were considered as possible biomarkers of final BCVA and CMT. We also collected the data concerning the need for additional treatment including sectorial laser photocoagulation, change to another anti-VEGF agent, or intravitreal corticosteroid injection. Results: A total of 161 eyes were analyzed. BCVA significantly improved from baseline to 12- month follow-up (0.6 and 0.4 logMAR, respectively; P < 0.01). CMT decreased significantly during the follow-up period (from 498.0 to 325.0 μm; P < 0.01). Final BCVA correlated positively with baseline BCVA (P < 0.01, r = 0.57). Older age at diagnosis and baseline SD-OCT findings including CMT, disruption of the retinal inner layers, retinal pigment epithelium (RPE) damage, and impairment of the ellipsoid zone and external limiting membrane negatively affected final BCVA (P < 0.01). Multiple regression analysis identified age and BCVA at baseline as the only independent predictors of final BCVA (P = 0.001 and P < 0.01, respectively). No association was found between clinical data, SD-OCT parameters, and final CMT. Conclusion: Various clinical and SD-OCT parameters are prognostically relevant for visual improvement in ME secondary to BRVO. Age at diagnosis and baseline BCVA were found to be independent predictors of visual outcome.
- 16 September 2024
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 19 (3) , 324-333
Open AccessPredictive Factors for Functional and Anatomical Outcomes After Anti-VEGF Treatment for Macular Edema in Patients with Branch Retinal Vein Occlusion
Purpose: This study aimed to identify predictive factors for the improvement of best-corrected visual acuity (BCVA) and reduction of central macular thickness (CMT) after treatment of macular edema (ME) due to branch retinal vein occlusion (BRVO) in a real-world setting. Methods: This retrospective study included patients with ME secondary to BRVO who were treated with intravitreal injection of bevacizumab as the first-line therapy and were followed up for 12 months. Demographic and clinical data, in addition to baseline spectral domain optical coherence tomography (SD-OCT) features, were considered as possible biomarkers of final BCVA and CMT. We also collected the data concerning the need for additional treatment including sectorial laser photocoagulation, change to another anti-VEGF agent, or intravitreal corticosteroid injection. Results: A total of 161 eyes were analyzed. BCVA significantly improved from baseline to 12- month follow-up (0.6 and 0.4 logMAR, respectively; P < 0.01). CMT decreased significantly during the follow-up period (from 498.0 to 325.0 μm; P < 0.01). Final BCVA correlated positively with baseline BCVA (P < 0.01, r = 0.57). Older age at diagnosis and baseline SD-OCT findings including CMT, disruption of the retinal inner layers, retinal pigment epithelium (RPE) damage, and impairment of the ellipsoid zone and external limiting membrane negatively affected final BCVA (P < 0.01). Multiple regression analysis identified age and BCVA at baseline as the only independent predictors of final BCVA (P = 0.001 and P < 0.01, respectively). No association was found between clinical data, SD-OCT parameters, and final CMT. Conclusion: Various clinical and SD-OCT parameters are prognostically relevant for visual improvement in ME secondary to BRVO. Age at diagnosis and baseline BCVA were found to be independent predictors of visual outcome.
- Open Access
- 1 April 2024
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 18, 1057-1066
Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study
Purpose: To report the long-term functional, anatomical and safety outcomes of 0.2 μg/day fluocinolone acetonide 0.19mg in patients with persistent or recurrent diabetic macular edema (DME). Methods: Retrospective, observational, single-center study of patients with recurrent or persistent DME. All patients received 0.2 μg/day of fluocinolone acetonide 0.19mg, and data were collected at baseline and months 1, 3, 6, 12, 24 and 36 after implantation. Outcomes measured included best-corrected visual acuity (BCVA), central macular thickness (CMT), intraocular pressure (IOP), and safety outcomes. Results: A total of 28 eyes from 28 patients were included. The mean age was 66.5 years (95% CI 62.8– 70.2) with a mean duration of DME of 8.8 years (95% CI 7.7– 10.0). Only two eyes were phakic. Mean follow-up was 25.4 months (95% CI 21.2– 29.6). Mean BCVA at baseline was 48.6 ETDRS letters (95% CI 41.3– 55.8) and improved as early as month 1 of follow-up with a mean gain in BCVA of 7.8 (95% CI 4.3– 11.3) ETDRS letters (p< 0.001). Statistically significant improvements in BCVA were also observed at months 6, 12 and 24. At baseline, patients had a mean CMT of 530.5μm (95% CI 463.0– 598.0), and a decrease in CMT was observed, starting at the first month of follow-up (mean CMT reduction of − 170.5μm, 95% CI − 223.8– − 117.1; p< 0.001). Statistically significant decreases in CMT were also observed at months 6, 12, 24, and 36, with the maximum decrease observed at month 12 (p< 0.001). Mean IOP at baseline was 16.4mmHg (95% CI 15.3– 17.5) and nine eyes (32.1%) had an IOP ≥ 21mmHg during follow-up. Conclusion: Our results support the effectiveness and safety profile of fluocinolone acetonide. Although additional long-term real-world evidence is required, fluocinolone acetonide may represent a safe strategy for daily, low-dose, sustained and localized release to the posterior segment of the eye, providing both functional and anatomical benefits in DME.
- 1 April 2024
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 18, 1057-1066
Open AccessReal-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study
Purpose: To report the long-term functional, anatomical and safety outcomes of 0.2 μg/day fluocinolone acetonide 0.19mg in patients with persistent or recurrent diabetic macular edema (DME). Methods: Retrospective, observational, single-center study of patients with recurrent or persistent DME. All patients received 0.2 μg/day of fluocinolone acetonide 0.19mg, and data were collected at baseline and months 1, 3, 6, 12, 24 and 36 after implantation. Outcomes measured included best-corrected visual acuity (BCVA), central macular thickness (CMT), intraocular pressure (IOP), and safety outcomes. Results: A total of 28 eyes from 28 patients were included. The mean age was 66.5 years (95% CI 62.8– 70.2) with a mean duration of DME of 8.8 years (95% CI 7.7– 10.0). Only two eyes were phakic. Mean follow-up was 25.4 months (95% CI 21.2– 29.6). Mean BCVA at baseline was 48.6 ETDRS letters (95% CI 41.3– 55.8) and improved as early as month 1 of follow-up with a mean gain in BCVA of 7.8 (95% CI 4.3– 11.3) ETDRS letters (p< 0.001). Statistically significant improvements in BCVA were also observed at months 6, 12 and 24. At baseline, patients had a mean CMT of 530.5μm (95% CI 463.0– 598.0), and a decrease in CMT was observed, starting at the first month of follow-up (mean CMT reduction of − 170.5μm, 95% CI − 223.8– − 117.1; p< 0.001). Statistically significant decreases in CMT were also observed at months 6, 12, 24, and 36, with the maximum decrease observed at month 12 (p< 0.001). Mean IOP at baseline was 16.4mmHg (95% CI 15.3– 17.5) and nine eyes (32.1%) had an IOP ≥ 21mmHg during follow-up. Conclusion: Our results support the effectiveness and safety profile of fluocinolone acetonide. Although additional long-term real-world evidence is required, fluocinolone acetonide may represent a safe strategy for daily, low-dose, sustained and localized release to the posterior segment of the eye, providing both functional and anatomical benefits in DME.
- Open Access
- 1 April 2023
- Published by Medknow in Indian Journal of Ophthalmology - Case Reports
- Vol. 3 (2) , 622
Small-cell lung carcinoma diagnosis through an iris tumor
- 1 April 2023
- Published by Medknow in Indian Journal of Ophthalmology - Case Reports
- Vol. 3 (2) , 622
Open AccessSmall-cell lung carcinoma diagnosis through an iris tumor
- Open Access
- 9 February 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (7) , 628-638
Eyes Shut Homolog-Associated Retinal Degeneration
- 9 February 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (7) , 628-638
Open AccessEyes Shut Homolog-Associated Retinal Degeneration
- Open Access
- 10 January 2023
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 261 (6) , 1701-1712
Automated macular segmentation can distinguish glaucomatous from compressive optic neuropathy
Purpose: To compare macular damage in glaucomatous optic neuropathy (GON) and compressive optic neuropathy (CON) and assess its diagnostic accuracy in distinguishing between diseases. Methods: Observational, cross-sectional, single-center study. Patients with GON, CON, and healthy controls were included according to the eligibility criteria. An automated spectral-domain optical coherence tomography (SD-OCT) algorithm was used to segment the circumpapilary retinal nerve fiber layer (cpRNFL) and macula. The layer thickness was measured in each sector according to the Early Treatment Diabetic Retinopathy Study and the 6-sector Garway-Heath-based grids. Data was compared across all study groups, and the significance level was set at 0.05. Results: Seventy-five eyes of 75 participants, 25 with GON, 25 with CON, and 25 healthy controls (CG), were included. Macular thickness was diminished in the ganglion cell complex of GON and CON patients compared to CG (pp<0.001) than combining parameters in each layer separately. Conclusion: Our findings suggest that the evaluation of macular segmented layers damage by SD-OCT may be a helpful add-on tool in the differential diagnosis between GON and CON.
- 10 January 2023
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 261 (6) , 1701-1712
Open AccessAutomated macular segmentation can distinguish glaucomatous from compressive optic neuropathy
Purpose: To compare macular damage in glaucomatous optic neuropathy (GON) and compressive optic neuropathy (CON) and assess its diagnostic accuracy in distinguishing between diseases. Methods: Observational, cross-sectional, single-center study. Patients with GON, CON, and healthy controls were included according to the eligibility criteria. An automated spectral-domain optical coherence tomography (SD-OCT) algorithm was used to segment the circumpapilary retinal nerve fiber layer (cpRNFL) and macula. The layer thickness was measured in each sector according to the Early Treatment Diabetic Retinopathy Study and the 6-sector Garway-Heath-based grids. Data was compared across all study groups, and the significance level was set at 0.05. Results: Seventy-five eyes of 75 participants, 25 with GON, 25 with CON, and 25 healthy controls (CG), were included. Macular thickness was diminished in the ganglion cell complex of GON and CON patients compared to CG (pp<0.001) than combining parameters in each layer separately. Conclusion: Our findings suggest that the evaluation of macular segmented layers damage by SD-OCT may be a helpful add-on tool in the differential diagnosis between GON and CON.
- Open Access
- 1 November 2022
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 16, 3741-3749
Modified Deep Anterior Lamellar Keratoplasty Technique to Rescue Failed Penetrating Keratoplasty
Purpose: To describe a modified deep anterior lamellar keratoplasty (DALK) technique to rescue failed penetrating keratoplasty (PK) grafts and report its results. Patients and Methods: Retrospective, case-series analysis of patients who underwent modified DALK to rescue failed corneal grafts after PK was included. Every patient had corneal graft failure (GF) diagnosis due to anterior corneal (epithelium, Bowman’s, and stroma layers) or refraction disorders uncorrectable with conservative management. The main objective of the surgery and primary outcome of the study was the improvement of corrected distance visual acuity (CDVA). The study’s secondary outcome was the frequency of intra- and postoperative complications. Results: This series included four eyes from three patients with a mean age of 57.7 years (range: 51– 63 years). Mean follow-up of patients was thirteen months (range: 12– 15 months). During follow-up, continuous improvement of corneal transparency and CDVA was observed in every patient. The only intraoperative complication reported was a peripheric DM microperforations of previous graft–host junction in two eyes. No signs of double anterior chamber, endothelial failure, GF, glaucoma, or other side effects were reported. Conclusion: Our results suggest that modified DALK in patients with GF after PK, preserving a healthy endothelium, is surgically feasible. However, further studies are needed to compare this procedure to PK and other DALK technique variations.
- 1 November 2022
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 16, 3741-3749
Open AccessModified Deep Anterior Lamellar Keratoplasty Technique to Rescue Failed Penetrating Keratoplasty
Purpose: To describe a modified deep anterior lamellar keratoplasty (DALK) technique to rescue failed penetrating keratoplasty (PK) grafts and report its results. Patients and Methods: Retrospective, case-series analysis of patients who underwent modified DALK to rescue failed corneal grafts after PK was included. Every patient had corneal graft failure (GF) diagnosis due to anterior corneal (epithelium, Bowman’s, and stroma layers) or refraction disorders uncorrectable with conservative management. The main objective of the surgery and primary outcome of the study was the improvement of corrected distance visual acuity (CDVA). The study’s secondary outcome was the frequency of intra- and postoperative complications. Results: This series included four eyes from three patients with a mean age of 57.7 years (range: 51– 63 years). Mean follow-up of patients was thirteen months (range: 12– 15 months). During follow-up, continuous improvement of corneal transparency and CDVA was observed in every patient. The only intraoperative complication reported was a peripheric DM microperforations of previous graft–host junction in two eyes. No signs of double anterior chamber, endothelial failure, GF, glaucoma, or other side effects were reported. Conclusion: Our results suggest that modified DALK in patients with GF after PK, preserving a healthy endothelium, is surgically feasible. However, further studies are needed to compare this procedure to PK and other DALK technique variations.
- 3 September 2021
- Published by Wolters Kluwer Health in Cornea
- Vol. 41 (8) , 990-994
Topical Insulin—Utility and Results in Refractory Neurotrophic Keratopathy in Stages 2 and 3
Purpose: The purpose of this study was to evaluate the clinical outcome of patients with refractory neurotrophic keratopathy (NK) in stages 2 and 3 treated with topical insulin. Methods: Retrospective analysis of eyes with NK in stages 2 and 3 refractory to standard medical and/or surgical treatment which were treated with topical insulin (1 unit per mL). This treatment was applied 4 times per day and was continued until the persistent epithelial defect (PED) or ulcer resolved. The primary outcome of the study was the complete reepithelialization of the PED or persistent ulcer. “Best-corrected visual acuity” pretreatment and posttreatment, “days until complete reepithelialization” data, and anterior segment photographs were obtained. Outcome measures were compared before and after treatment in both groups using paired and independent samples t tests. Results: Twenty-one eyes were included in this study, and 90% achieved complete reepithelialization of the PED and/or persistent ulcer within 7 to 45 days of follow-up. The mean number of days until complete reepithelialization was significantly lower in NK stage 2 (18 ± 9 days) when compared with NK stage 3 (29 ± 11 days) (P = 0.025). The best-corrected visual acuity improved significantly in both NK stage 2 (P < 0.001) and NK stage 3 (P = 0.004). No side effects were reported during the follow-up. Conclusions: Our results suggest that topical insulin drops may be an effective therapeutic in refractory NK. This therapy may prove extremely useful because of its low cost and high accessibility.
- 3 September 2021
- Published by Wolters Kluwer Health in Cornea
- Vol. 41 (8) , 990-994
Topical Insulin—Utility and Results in Refractory Neurotrophic Keratopathy in Stages 2 and 3
Purpose: The purpose of this study was to evaluate the clinical outcome of patients with refractory neurotrophic keratopathy (NK) in stages 2 and 3 treated with topical insulin. Methods: Retrospective analysis of eyes with NK in stages 2 and 3 refractory to standard medical and/or surgical treatment which were treated with topical insulin (1 unit per mL). This treatment was applied 4 times per day and was continued until the persistent epithelial defect (PED) or ulcer resolved. The primary outcome of the study was the complete reepithelialization of the PED or persistent ulcer. “Best-corrected visual acuity” pretreatment and posttreatment, “days until complete reepithelialization” data, and anterior segment photographs were obtained. Outcome measures were compared before and after treatment in both groups using paired and independent samples t tests. Results: Twenty-one eyes were included in this study, and 90% achieved complete reepithelialization of the PED and/or persistent ulcer within 7 to 45 days of follow-up. The mean number of days until complete reepithelialization was significantly lower in NK stage 2 (18 ± 9 days) when compared with NK stage 3 (29 ± 11 days) (P = 0.025). The best-corrected visual acuity improved significantly in both NK stage 2 (P < 0.001) and NK stage 3 (P = 0.004). No side effects were reported during the follow-up. Conclusions: Our results suggest that topical insulin drops may be an effective therapeutic in refractory NK. This therapy may prove extremely useful because of its low cost and high accessibility.
- 23 August 2021
- Published by Taylor & Francis in Orbit
- Vol. 41 (5) , 558-562
Plasma rich in growth factors (PRGF -ENDORET®) to rescue necrotized orbital dermis-fat grafts
We report on the clinical course of three patients treated with topical plasma rich in growth factors (PRGF) to rescue dermal-fat grafts (DFG) with graft ulceration (GU).A retrospective, case-serie...
- 23 August 2021
- Published by Taylor & Francis in Orbit
- Vol. 41 (5) , 558-562
Plasma rich in growth factors (PRGF -ENDORET®) to rescue necrotized orbital dermis-fat grafts
We report on the clinical course of three patients treated with topical plasma rich in growth factors (PRGF) to rescue dermal-fat grafts (DFG) with graft ulceration (GU).A retrospective, case-serie...